DSM-5: a collection of psychiatrist views on the changes, controversies, and future directions

BMC Medicine

Paul Lysaker⁴  Martin Brüne^1,13  Martin Preisig⁵  Gin S Malhi⁹  Michael Berk³  Florian Seemüller⁸  Carmine M Pariante^1,11  Dan J Stein^1,14  Simon Wessely¹  Richard A Bryant^1,12  Harriet L MacMillan⁶  Michael Rutter²  Daniel Weinberger^1,10  Charles B Nemeroff⁷ 

[1] Department of Psychological Medicine, Institute of Psychiatry, King’s College London, Weston Education Centre, Cutcombe Road, London, UK;MRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Kings College London, De Crespigny Park, Denmark Hill, London, UK;Department of Psychiatry, Orygen Research Centre and the Florey Institute for Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC 3052, Australia;Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN, USA;Department of Psychiatry, University Hospital of Lausanne, Site de Cery, Prilly 1008, Switzerland;Departments of Psychiatry and Behavioural Neurosciences, and Department of Pediatrics, Offord Centre for Child Studies, McMaster University, 1280 Main St. West, Hamilton, ON, Canada;Department of Psychiatry and Behavioral Sciences, University of Miami, Leonard M. Miller School of Medicine, Miami, FL, USA;Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Nussbaumstr.7, Munich 80336, Germany;CADE Clinic, Department of Psychiatry, Royal North Shore Hospital, Sydney, Australia;Departments of Psychiatry, Neurology, Neuroscience and The Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Lieber Institute for Brain Development, 855 North Wolfe Street, Baltimore, MD 21205, USA;Department of Psychological Medicine, Institute of Psychiatry, Kings College London, Room 2-055, The James Black Centre, 125 Coldharbour Lane, London, UK;School of Psychology, University of New South Wales, Sydney, NSW 2052, Australia;Division of Cognitive Neuropsychiatry and Psychiatric Preventive Medicine, LWL University Hospital, Ruhr-University Bochum, Alexandrinenstraße 1, Bochum D-44791, Germany;Department of Psychiatry & Mental Health, University of Cape Town and Groote Schuur Hospital, Observatory, J2, Anzio Rd, Cape Town 7925, South Africa

关键词: Schizophrenia;    Depression;    Obsessive-compulsive disorders;    Bipolar;    Mood disorders;    PTSD;    Autism;    Psychiatry;    DSM-5;   

Others  :  855714
DOI  :  10.1186/1741-7015-11-202

 received in 2013-07-26, accepted in 2013-08-16,  发布年份 2013

【 摘 要 】

The recent release of the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) by the American Psychiatric Association has led to much debate. For this forum article, we asked BMC Medicine Editorial Board members who are experts in the field of psychiatry to discuss their personal views on how the changes in DSM-5 might affect clinical practice in their specific areas of psychiatric medicine. This article discusses the influence the DSM-5 may have on the diagnosis and treatment of autism, trauma-related and stressor-related disorders, obsessive-compulsive and related disorders, mood disorders (including major depression and bipolar disorders), and schizophrenia spectrum disorders.

【 授权许可】

   
2013 Nemeroff et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 5th edition. Arlington, VA: American Psychiatric Association; 2013.
• [2]American Psychiatric Association: Highlights of Changes from DSM-IV-TR to DSM-5. Arlington, VA: American Psychiatric Association; 2013.
• [3]Friedman MJ, Resick PA, Bryant RA, Brewin CR: Considering PTSD for DSM-5. Depress Anxiety 2011, 28:750-769.
• [4]Scheeringa MS, Myers L, Putnam FW, Zeanah CH: Diagnosing PTSD in early childhood: an empirical assessment of four approaches. J Trauma Stress 2012, 25:359-367.
• [5]Cohen JA, Deblinger E, Mannarino AP, Steer RA: A multisite, randomized controlled trial for children with sexual abuse-related PTSD symptoms. J Am Acad Child Adolesc Psychiatry 2004, 43:393-402.
• [6]Cohen JA, Mannarino AP, Iyengar S: Community treatment of posttraumatic stress disorder for children exposed to intimate partner violence: a randomized controlled trial. Arch Pediatr Adolesc Med 2011, 165:16-21.
• [7]Lieberman AF, Van Horn P, Ippen CG: Toward evidence-based treatment: child–parent psychotherapy with preschoolers exposed to marital violence. J Am Acad Child Adolesc Psychiatry 2005, 44:1241-1248.
• [8]Lieberman AF, Ghosh Ippen C, Van Horn P: Child–parent psychotherapy: 6-month follow-up of a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 2006, 45:913-918.
• [9]Goldman Fraser J, Lloyd SW, Murphy RA, Crowson MM, Casanueva C, Zolotor A, Coker-Schwimmer M, Letourneau K, Gilbert A, Swinson Evans T, Crotty K, Viswanathan M: Exposure to Trauma: Comparative Effectiveness of Interventions Addressing Maltreatment. Comparative Effectiveness Review No. 89. (Prepared by the RTIUNC Evidence-based Practice Center under Contract No. 290-2007-10056-I.) AHRQ Publication No. 13-EHC002-EF. Rockville, MD: Agency for Healthcare Research and Quality; 2013. http://effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=1463 webcite
• [10]American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (DSM-III). 3rd edition. Washington, DC: American Psychiatric Association; 1980.
• [11]Wessely S, Jones E: Psychiatry and the lessons of Vietnam: what were they and are they still relevant? War and Society 2004, 22:89-103.
• [12]Yufik T, Simms LJ: A meta-analytic investigation of the structure of posttraumatic stress disorder symptoms. J Abnorm Psychol 2010, 119:764-776.
• [13]van Emmerik AA, Kamphuis JH: Testing a SSM-5 reformulation of posttraumatic stress disorder: Impact on prevalence and comorbidity among treatment-seeking civilian trauma survivors. J Trauma Stress 2011, 24:213-217.
• [14]Stein MB, Walker JR, Hazen AL, Forde DR: Full and partial posttraumatic stress disorder: Findings from a community survey. Am J Psychiatry 1997, 154:1114-1119.
• [15]Galatzer-Levy I, Bryant RA: 636,120 ways to have posttraumatic stress disorder: the relative merits of categorical and dimensional approaches to posttraumatic stress. Persp Psychol Sciin press
• [16]Maercker A, Brewin C, Bryant R, Cloitre M, Reed G, van Ommeren M, Humayun A, Jones L, Kagee A, Llosa A, Rousseau C, Somasundaram D, Souza R, Suzuki Y, Weissbecker I, Wessely S, First M, Saxena S: Proposals for mental disorders specifically associated with stress in the ICD-11. Lancet 2013, 381:1683-1685.
• [17]Hollander E, Zohar J, Sirovataka P, Regier D: Obsessive-Compulsive Spectrum Disorders: Refining the Research Agenda for DSM-V. Arlington, VA: American Psychiatric Publishing Inc; 2011.
• [18]Leckman JF, et al.: Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depress Anxiety 2010, 27:507-27.
• [19]Phillips KA, et al.: Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety 2010, 27:528-55.
• [20]Stein DJ, et al.: Should OCD be classified as an anxiety disorder in DSM-V? Depress Anxiety 2010, 27:495-506.
• [21]Phillips KA, et al.: Body dysmorphic disorder: some key issues for DSM-V. Depress Anxiety 2010, 27:573-91.
• [22]Mataix-Cols D, et al.: Hoarding disorder: a new diagnosis for DSM-V? Depress Anxiety 2010, 27:556-572.
• [23]Stein DJ, et al.: Trichotillomania (hair pulling disorder), skin picking disorder, and stereotypic movement disorder: toward DSM-V. Depress Anxiety 2010, 27:611-26.
• [24]Walkup JT, Ferrão Y, Leckman JF, Stein DJ, Singer H: Tic disorders: some key issues for DSM-V. Depress Anxiety 2010, 27:600-10.
• [25]Feusner JD, Phillips KA, Stein DJ: Olfactory reference syndrome: issues for DSM-V. Depress Anxiety 2010, 27:592-9.
• [26]Bienvenu OJ, et al.: Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med 2012, 42:1-13.
• [27]Mataix-Cols D, Billotti D, de la Cruz LF, Nordsletten AE: The London field trial for hoarding disorder. Psychol Med 2013, 43:837-47.
• [28]Lochner C, et al.: DSM-5 field survey: hair-pulling disorder (trichotillomania). Depress Anxiety 2012, 29:1025-31.
• [29]Lochner C, Grant JE, Odlaug BL, Stein DJ: DSM-5 field survey: skin picking disorder. Ann Clin PsychiatryJ Am Acad Clin Psychiatrists 2012, 24:300-4.
• [30]Stein DJ, Phillips KA: Patient advocacy and dsm-5. BMC medicine 2013, 11:133.
• [31]Stein DJ, Craske MG, Friedman MJ, Phillips KA: Meta-structure issues for the DSM-5: How Do anxiety disorders, obsessive-compulsive and related disorders, post-traumatic disorders, and dissociative disorders Fit together? Curr Psychiatry Rep 2011, 13:248-50.
• [32]Grant JE, et al.: Skin picking disorder. Am J Psychiatry 2012, 169:1143-9.
• [33]Stein DJ, et al.: What is a mental/psychiatric disorder? From DSM-IV to DSM-V. Psychol Med 2010, 40:1759-65.
• [34]Stein DJ, et al.: Obsessive-compulsive disorder: diagnostic and treatment issues. Psychiatr Clin N Am 2009, 32:665-85.
• [35]Phillips KA, Hart AS, Simpson HB, Stein DJ: Delusional versus nondelusional body dysmorphic disorder: recommendations for DSM-5. CNS Spectrums 2013, 1-11. available on CJO2013
• [36]Matsunaga H, et al.: Symptom structure in Japanese patients with obsessive-compulsive disorder. Am J Psychiatry 2008, 165:251-3.
• [37]Mataix-Cols D, Pertusa A, Leckman JF: Issues for DSM-V: how should obsessive-compulsive and related disorders be classified? Am J Psychiatry 2007, 164:1313-4.
• [38]Stein DJ: Is disorder X in category or spectrum Y? General considerations and application to the relationship between obsessive-compulsive disorder and anxiety disorders. Depress Anxiety 2008, 25:330-5.
• [39]Kendler KS, Myers J, Zisook S: Does bereavement-related major depression differ from major depression associated with other stressful life events? Am J Psychiatry 2008, 165:1449-1455.
• [40]Blader JC, Carlson GA: Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996–2004. Biol Psychiatry 2007, 62:107-114.
• [41]Regier DA, Narrow WE, Clarke DE, Kraemer HC, Kuramoto SJ, Kuhl EA, Kupfer DJ: DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry 2013, 170:59-70.
• [42]Wakefield JC: DSM-5: proposed changes to depressive disorders. Curr Med Res Opin 2012, 28:335-343.
• [43]Nierenberg AA, Kansky C, Brennan BP, Shelton RC, Perlis R, Iosifescu DV: Mitochondrial modulators for bipolar disorder: a pathophysiologically informed paradigm for new drug development. Aust NZJ Psychiatry 2013, 47:26-42.
• [44]Swann AC, Lafer B, Perugi G, Frye MA, Bauer M, Bahk WM, Scott J, Ha K, Suppes T: Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. Am J Psychiatry 2013, 170:31-42. doi:10.1176/appi.ajp.2012.12030301
• [45]Dodd S, Kulkarni J, Berk L, Ng F, Fitzgerald PB, de Castella AR, Filia S, Filia K, Montgomery W, Kelin K, Smith M, Brnabic A, Berk M: A prospective study of the impact of subthreshold mixed states on the 24-month clinical outcomes of bipolar I disorder or schizoaffective disorder. J Affect Disord 2010, 124:22-8.
• [46]Koukopoulos A, Sani G: DSM-5 criteria for depression with mixed features: a farewell to mixed depression. Acta Psychiatr Scand 2013, 1-13. doi:10.1111/acps.12140
• [47]McIntyre RS, Tohen M, Berk M, Zhao J, Weiller E: DSM-5 mixed specifier for manic episodes: evaluating the effect of depressive features on severity and treatment outcome using asenapine clinical trial data. J Affect Disord 2013. in press http://dx.doi.org/10.1016/j.jad.2013.04.025i webcite
• [48]Copeland WE, Angold A, Costello EJ, Egger H: Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder. Am J Psychiatry 2013, 170:173-179. doi:10.1176/appi.ajp.2012.12010132
• [49]Axelson D, Findling RL, Fristad MA, Kowatch RA, Youngstrom EA, Horwitz SM, Arnold LE, Frazier TW, Ryan N, Demeter C, Gill MK, Hauser-Harrington JC, Depew J, Kennedy SM, Gron BA, Rowles BM, Birmaher B: Examining the proposed disruptive mood dysregulation disorder diagnosis in children in the Longitudinal Assessment of Manic Symptoms study. J Clin Psychiatry 2012, 73:1342-50. doi:10.4088/JCP.12m07674
• [50]Zisook S, Corruble E, Duan N, Iglewicz A, Karam EG, Lanouette N, Lebowitz B, Pies R, Reynolds C, Seay K, Katherine Shear M, Simon N, Young IT: The bereavement exclusion and DSM-5. Depress Anxiety 2012, 29:425-443.
• [51]Porter R, Mulder R, Lacey C: DSM-5 and the elimination of the major depression bereavement exclusion. Aust NZJ Psychiatry 2013, 47:391-3.
• [52]Taylor MA, Fink M: Restoring melancholia in the classification of mood disorders. J Affect Disord 2008, 105:1-14.
• [53]Kocsis JH: Melancholia as a distinct mood disorder? Recommendations for DSM-5. Am J Psychiatry 2010, 167:1534.
• [54]Cuthbert BN, Insel TR: Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med 2013, 14:126.
• [55]Adam D: On the spectrum. Nature 2013, 496:416-418.
• [56]Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, Barale F, Caverzasi E, McGuire P: Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 2012, 69:220-9.
• [57]McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ: Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust NZJ Psychiatry 2006, 40:616-22.
• [58]Morrison AP, French P, Stewart SL, Birchwood M, Fowler D, Gumley AI, Jones PB, Bentall RP, Lewis SW, Murray GK, Patterson P, Brunet K, Conroy J, Parker S, Reilly T, Byrne R, Davies LM, Dunn G: Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ 2012, 344:e2233.
• [59]Preti A, Cella M: Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophr Res 2010, 123:30-6.
• [60]American Heart Association Scientific Statement: Recommendations for blood pressure measurement in humans and experimental animals. Part 1: blood pressure measurement in humans: a statement for professionals from the subcommittee of professional and public education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005, 45:142-161.
• [61]Kelleher I, Harley M, Murtagh A, Cannon M: Are screening instruments valid for psychotic-like experiences? a validation study of screening questions for psychotic-like experiences using in-depth clinical interview. Schizophr Bull 2011, 37:362-369.
• [62]McGlashan TH, Miller TJ, Woods SW: Pre-onset detection and intervention research in schizophrenia psychoses: current estimates of benefit and risk. Schizophr Bull 2001, 27:563-70.
• [63]Yung A, Phillips LJ, McGorry PD, et al.: Comprehensive Assessment of At-Risk Mental States (CAARMS). Melbourne: PACE Clinic, University of Melbourne; 2001.
• [64]Kendler KS, Gruenberg AM, Tsuang MT: Subtype stability in schizophrenia. Am J Psychiatry 1985, 142:827-832.
• [65]Fabrega H Jr: Phylogenetic and Cultural Basis of Mental Illness. New Brunswick: Rutgers University Press; 2002.
• [66]Brüne M, Belsky J, Fabrega H Jr, Feierman JR, Gilbert P, Glantz K, Polimeni J, Price JS, Sanjuan J, Sullivan R, Troisi A, Wilson DR: The crisis of psychiatry – insights and prospects from evolutionary theory. World Psychiatry 2012, 11:55-57.
• [67]Kumar A, Sharma P, Das S, Nath K, Talukdar U, Bhagabati D: Insight in psychotic disorder: relation with psychopathology and frontal lobe function. PsychopathologyIn press
• [68]Lysaker PH, Vohs J, Hillis JD, Kukla M, Popolo R, Salvatore G, Dimaggio G: Poor insight in schizophrenia: contributing factors, consequences, and emerging treatment approaches. Expert Rev NeurotherIn press
• [69]Van der Meer L, De Vos AE, Stiekema AP, Pijnenborg GH, Van Tol MJ, Nolen WA, David AS, Aleman A: Insight in schizophrenia: involvement of self-reflection networks? Schizophr BullIn press
• [70]Silverstein SM, Bellack AS: Scientific agenda for the concept of recovery as it applies to schizophrenia. Clin Psychol Rev 2008, 28:1108-24.
• [71]Slade M: Personal Recovery and Mental Illness: A Guide for Mental Health Professionals. NY, NY: Cambridge University Press; 2009.
• [72]Bleuler E: Dementia Praecox or the Group of Schizophrenias. New York: International Universities Press; 1950.
• [73]Lysaker PH, Bob P, Pec O, Hamm J, Kukla M, Vohs J, Popolo R, Salvatore G, Dimaggio G: Metacognition as a link which connects brain to behavior in schizophrenia. Translational NeurosciIn press